Azienda Unita Sanitaria Locale Della Romagna

The site’s investigations address idiopathic pulmonary fibrosis, a progressive lung disease, by testing new agents that aim to preserve lung capacity and improve patient outcomes.

• Investigating novel anti‑fibrotic compounds
• Monitoring changes in forced vital capacity
• Evaluating safety and tolerability profiles

Azienda Unita Sanitaria Locale Della Romagna provides a collaborative environment for these studies, fostering advances in respiratory care.

Clinical work focuses on pancreatic exocrine insufficiency in patients with advanced pancreatic cancer, exploring how enzyme supplementation can restore nutrition and enhance treatment tolerance.

• Pancreatic enzyme replacement therapy (PERT)
• Nutritional status and weight gain assessment
• Quality‑of‑life measurements

The Forlì‑based department leverages its expertise to improve digestive health outcomes for vulnerable cancer patients.

Researchers evaluate supportive strategies for unresectable pancreatic cancer, aiming to boost performance status and potentially extend survival through combined therapeutic approaches.

• Integration of enzyme therapy with chemotherapy
• Optimization of patient performance status
• Exploration of survival benefits

At the U.O. Pneumologia, multidisciplinary collaboration supports innovative cancer care research.